In relation to Alzheimer ́s disease and other dementias, it has been proposed that differential levels of brevican and the fragments generated after ADAMTS-4 proteolysis could be employed to distinguish among different types of dementias [141]. This evidence concerns the gene ADAMTS4 and dementia.